Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: World's first malaria vaccine, how to shape research to advance global health, and lotion that protects from malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
NIH program’s new leadership council lacks global health voices

Last week, the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) announced a key benchmark for the program—the formation of its new Advisory Council, which will meet for the first time later this month.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
What does the private sector really think about priority review vouchers?

In this guest post, Rianna Stefanakis—manager of Research and Policy at BIO Ventures for Global Health (BVGH)—writes about a new BVGH study this week in PLoS Neglected Tropical Diseases. This post originally appeared on the BVGH blog.

Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Why aren’t the candidates talking about R&D?

Next week marks a significant step in this year’s presidential elections, as Mitt Romney will become the official nominee for the Republican Party at its convention in Florida.

GHTC
Read More
PATH/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A global partnership for vaccine design

In this guest post, Margaret McGlynn, president & CEO of the International AIDS Vaccine Initiative (IAVI), writes about a new partnership between IAVI and the Indian government.

Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What’s Ahead on the Hill

In this feature on Breakthroughs, we provide an update on what’s currently happening with global health in Congress and an outlook for future legislative activity.

GHTC
Read More
PATH/Richard Franco
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Lancet study captures global interest with news of major milestone in hunt for new TB drugs

In this guest post, Joanna Breitstein, director of communications at the TB Alliance, highlights the response to a new study that indicates a novel tuberculosis (TB) combination drug may be on the horizon.

TB Alliance
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
AIDS 2012: New prevention and treatment options at the forefront

As the XIX International AIDS Conference continues in Washington this week, research for new tools to prevent and treat HIV/AIDS is standing out as a major theme.

GHTC
Read More
AIDS 2012: Lessons for R&D advocates

The world of HIV/AIDS research and development (R&D) is changing dramatically, and sessions this week at the XIX International AIDS Conference have examine how R&D advocates need to adapt and adjust their strategies in this new environment.

GHTC
Read More
Photo: HIV Vaccine & Microbicides Resource Tracking Working Group
Investing in the End of the Pandemic: A New Era for HIV Prevention Research & Development

The following guest post from International AIDS Vaccine Initiative (IAVI) President and CEO Margaret McGlynn, AVAC Executive Director Mitchell Warren, and UNAIDS Executive Director Michel Sidibe comes on the release of Investing to End the AIDS Epidemic: A New Era for HIV Research & Development, a report from the HIV Vaccine & Microbicides Resource Tracking Working Group. This post originally appeared on Science Speaks.

AVAC
Read More
PATH/Lesley Reed
AIDS 2012: A resounding call for research

On the second day of the XIX International AIDS Conference, the need for a host of new tools to prevent and treat HIV/AIDS has already made it to the forefront of the agenda. Of particular note has been the resounding call for a vaccine to prevent HIV, with leading policymakers, scientists, and advocates saying that the world will never reach the end of AIDS without this powerful tool.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
AIDS 2012: Time to recognize and recommit US support for research

As the International AIDS Conference descends on DC later this month — the first time this conference has been held in the United States in over 20 years — there couldn’t be a better time to reflect on the scientific gains that have emerged over the past several months, and how a wide range of dedicated Americans are pushing this HIV/AIDS research forward.

GHTC
Read More